A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
Clinical trial NCT06696755 · RECRUITING
Trial details
- NCT number
- NCT06696755
- Sponsor
- AbbVie
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-03
- Primary completion
- 2027-11-01
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.